Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2008. Upgrade now.
Date Value
December 31, 2023 1.238B
September 30, 2023 1.208B
June 30, 2023 1.276B
December 31, 2022 1.273B
September 30, 2022 1.208B
June 30, 2022 1.332B
March 31, 2022 1.462B
December 31, 2021 1.560B
September 30, 2021 1.151B
June 30, 2021 1.015B
March 31, 2021 929.68M
December 31, 2020 891.05M
September 30, 2020 555.06M
June 30, 2020 535.43M
March 31, 2020 539.86M
December 31, 2019 534.35M
September 30, 2019 505.24M
June 30, 2019 498.30M
March 31, 2019 502.42M
December 31, 2018 485.02M
September 30, 2018 452.46M
June 30, 2018 407.07M
March 31, 2018 417.08M
December 31, 2017 397.01M
September 30, 2017 373.78M
Date Value
June 30, 2017 358.28M
March 31, 2017 333.69M
December 31, 2016 225.21M
September 30, 2016 216.50M
June 30, 2016 206.29M
March 31, 2016 205.69M
December 31, 2015 202.81M
September 30, 2015 199.59M
June 30, 2015 202.50M
March 31, 2015 176.87M
December 31, 2014 192.60M
September 30, 2014 197.47M
June 30, 2014 214.08M
March 31, 2014 214.50M
December 31, 2013 219.51M
September 30, 2013 239.78M
June 30, 2013 191.19M
March 31, 2013 191.50M
December 31, 2012 201.74M
September 30, 2012 204.55M
June 30, 2012 188.33M
March 31, 2012 193.32M
December 31, 2011 190.73M
September 30, 2011 202.14M
June 30, 2011 200.06M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

498.30M
Minimum
Jun 2019
1.560B
Maximum
Dec 2021
983.97M
Average
1.083B
Median

Shareholders Equity (Quarterly) Benchmarks

Centogene NV -27.95M
Affimed NV 63.90M
InflaRx NV 102.33M
MorphoSys AG 54.22M
BioNTech SE 21.56B

Shareholders Equity (Quarterly) Related Metrics